Kenvue Inc. (NYSE:KVUE) Receives Average Rating of “Hold” from Brokerages

Kenvue Inc. (NYSE:KVUE) has received a consensus recommendation of “Hold” from the sixteen analysts that are covering the stock, Marketbeat Ratings reports. Twelve analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $20.0769.

Several equities analysts recently weighed in on the stock. Barclays raised their target price on shares of Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a research note on Monday, November 10th. Edward Jones downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Citigroup increased their price target on Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research note on Wednesday. Evercore set a $18.00 price objective on Kenvue in a research note on Tuesday, October 28th. Finally, Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th.

Kenvue Stock Up 0.3%

Shares of KVUE opened at $18.73 on Monday. The business’s 50 day moving average is $17.54 and its 200 day moving average is $17.59. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue has a 12-month low of $14.02 and a 12-month high of $25.17. The company has a market capitalization of $35.88 billion, a PE ratio of 24.32, a price-to-earnings-growth ratio of 4.29 and a beta of 0.59.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.05. The business had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. Kenvue had a return on equity of 19.86% and a net margin of 9.72%.The firm’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.26 EPS. Research analysts expect that Kenvue will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th will be paid a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.4%. The ex-dividend date of this dividend is Wednesday, February 11th. Kenvue’s dividend payout ratio (DPR) is presently 107.79%.

Insider Buying and Selling at Kenvue

In related news, Director Jeffrey C. Smith bought 3,200,000 shares of the business’s stock in a transaction dated Friday, December 12th. The shares were purchased at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the transaction, the director owned 27,307,632 shares in the company, valued at $474,333,567.84. This trade represents a 13.27% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.17% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of Kenvue by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 233,246,267 shares of the company’s stock valued at $4,881,844,000 after acquiring an additional 4,101,880 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd raised its holdings in shares of Kenvue by 27.1% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 310,686 shares of the company’s stock worth $5,042,000 after purchasing an additional 66,192 shares during the last quarter. Aviva PLC lifted its position in Kenvue by 6.8% during the second quarter. Aviva PLC now owns 1,432,477 shares of the company’s stock valued at $29,982,000 after purchasing an additional 91,744 shares during the period. Bessemer Group Inc. boosted its holdings in Kenvue by 40.6% in the second quarter. Bessemer Group Inc. now owns 3,319,933 shares of the company’s stock valued at $69,487,000 after purchasing an additional 958,757 shares during the last quarter. Finally, Renaissance Capital LLC grew its position in Kenvue by 55.8% during the 3rd quarter. Renaissance Capital LLC now owns 980,436 shares of the company’s stock worth $15,912,000 after purchasing an additional 351,259 shares during the period. Institutional investors own 97.64% of the company’s stock.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.